πŸ‡ΊπŸ‡Έ FDA
Patent

US 10780074

Compounds and uses thereof

granted A61KA61K31/352A61K31/4155

Quick answer

US patent 10780074 (Compounds and uses thereof) held by PGI Drug Discovery LLC expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PGI Drug Discovery LLC
Grant date
Tue Sep 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
55
CPC classes
A61K, A61K31/352, A61K31/4155, A61K31/4178, A61K31/42